HomeNewsGlobal Pharma

Rossari Biotech's Subsidiary to Expand Ethoxylation Capacity

Rossari Biotech's Subsidiary to Expand Ethoxylation Capacity

The Board of Directors of Unitop Chemicals Private Limited, material subsidiary of Rossari Biotech Limited, at their meeting, reviewed and discussed the opportunities for growth and capacity expansion.

The existing Ethoxylation Capacity is 36,000 MTPA running at 95% capacity utilization. The company proposes to add 30,000 MTPA at an outlay of ~Rs. 128 crores.

The new capacity is expected to come on stream in a phased manner by Q3 FY25. The project will be funded through a mix of internal accruals and debt.

The expanded capacity will cater to the growing demand for agrochemicals, home and personal care, oil & gas and pharma sectors, in the specialty chemical space.

Read more on:
More news about: global pharma | Published by Manvi | October - 26 - 2023 | 658

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members